Olink Webinars

Combination of clinically significant proteins in plasma defines phenotype and combined biomarker associated with prognosis in critical COVID19 patients: Analysis using Olink PEA technology

Jan 27, 2022 3:06:24 PM / by Olink posted in Infectious diseases, Clinical research, Covid19, User group meetings

0 Comments

Speakers: Hisatake Matsumoto, Ph.D. (Assistant Professor at Osaka University)

Read More

Diabetes Mellitus is Associated with Accelerated Adverse Cardiac Remodeling in Patients with Hypertension: the REMODEL Study

Jan 27, 2022 2:55:02 PM / by Olink posted in Cardiovascular/metabolic diseases, Biostatistics, User group meetings, Diabetes

0 Comments

Speakers: Calvin Chin, M.D., Ph.D. (Director of CMR Center at the National Heart Centre Singapore)

Read More

Extracting biological insights from Olink data

Jan 27, 2022 2:45:20 PM / by Olink posted in Biomarkers, Multiomics, Biostatistics, User group meetings

0 Comments

Speakers: Emmett Sprecher (Senior Field Data Scientist, Olink Proteomics)

Read More

Dissecting the cerebrospinal immune responses in HIV infected patients using Olink

Jan 27, 2022 2:30:03 PM / by Olink posted in Neurology, Immunological diseases/Immunology, User group meetings, HIV

0 Comments

Speakers: Zicheng Hu, Ph.D. (Assistant Professor, Bakar Computational Health Sciences Institute, Department of Microbiology and Immunology, University of California San Francisco)

Read More

CSF biomarkers related to neuroinflammation using Olink assays in HIV and Alzheimer’s

Jan 27, 2022 2:24:14 PM / by Olink posted in Neurology, User group meetings, HIV, Alzheimers

0 Comments

Speakers: Douglas Galasko, Ph.D. (Professor of Neurosciences, University of California San Diego)

Read More

Custom assay panel development and validation for multiple sclerosis disease assessments using the Olink platform

Jan 27, 2022 2:15:30 PM / by Olink posted in Biomarkers, Multiomics, Multiple Sclerosis, User group meetings

0 Comments

Speakers: Ferhan Qureshi, Ph.D. (Vice President, Translational Research at Crohn's & Colitis Foundation)

Read More

Leveraging plasma and single-cell proteomics integration in translational studies

Jan 27, 2022 2:08:16 PM / by Olink posted in Plasma, Biomarkers, Covid19, User group meetings

0 Comments

Speakers: Dorien Feyaerts, Ph.D. (Post-doctoral researcher at Stanford University School of Medicine)

Read More

Targeted discovery proteomics in cardiovascular clinical trials

Jan 27, 2022 2:00:37 PM / by Olink posted in Cardiovascular diseases, Clinical research, User group meetings

0 Comments

Speakers: Christopher R. deFilippi, M.D. (Vice-Chairman of Academic Affairs at Inova Heart and Vascular Institute)

Read More

Proteomic profiling of tesamorelin in HIV-associated NAFLD

Jan 27, 2022 1:49:47 PM / by Olink posted in Proteomics, User group meetings, HIV, NAFLD

0 Comments

Speakers: Steven Grinspoon, M.D. (Professor of Medicine, Harvard Medical School, Chief, Metabolism Unit, MGH Endowed Chair in Neuroendocrinology and Metabolism, Director, Nutrition Obesity Research Center at Harvard)

Read More

Prognostic biomarkers for pediatric Crohn’s disease

Jan 27, 2022 1:19:13 PM / by Olink posted in Biomarkers, User group meetings, Chron's disease

0 Comments

Speakers:  Andrés Hurtado-Loreanzo, Ph.D. (Vice President, Translational Research at Crohn's & Colitis Foundation)

Read More

Recent Posts

See all Olink publications